To access this element change to forms mode OFF
Grant Award View - GA201586
Developing novel therapeutic approaches by using innate lymphoid cells...
GA ID:
GA201586
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$650,740.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Developing novel therapeutic approaches by using innate lymphoid cells in chronic kidney disease
Purpose:
Chronic kidney disease is a major cause of death and morbidity in Australia. Current strategies that delay progression of kidney disease are limited. Innate lymphoid cells (ILC) are a newly identified family of immune cells and include two protective subsets of ILC: regulatory ILC (ILCreg) and type 2 ILC (ILC2), which have been shown to suppress inflammation and promote tissue repair. The project will explore therapeutic potential of ILCreg and ILC2 in kidney disease.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2008347
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Sydney
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA